You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Author's response
  1. Mark Weatherall
  1. Correspondence to Dr Mark Weatherall, Wellington School of Medicine and Health Sciences, Department of Medicine, PB 7343, Wellington South, Wellington 6242, New Zealand; mark.weatherall{at}otago.ac.nz

https://doi.org/10.1136/thx.2010.149765

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank the authors for their interest in our paper.1 They raise an interesting and pertinent point about identifying patients at greater risk of β-agonist toxicity, a group in whom either the dose of β-agonist should be lowered, or …

    View Full Text

    Footnotes

    • Linked articles 137182.

    • Competing interests None.

    • Provenance and peer review Not commissioned; not externally peer reviewed.

    Linked Articles